Eil Lilly announces Zepbound to be sold directly to consumers

(4:4)

Eli Lilly CEO David Ricks: Projecting 32% total growth for company in 2025

(6:33)

Eli Lilly climbs after earnings, top analyst talks what's next for pharma giant

(5:9)

The David Rubenstein Show: Eli Lilly CEO Dave Ricks

(24:7)

Eli Lilly: Becoming the world's biggest pharmaceutical company 1876-2024

(2:1econd)

Eli Lilly to sell Zepbound directly to consumers without insurance coverage

(3:14)

Eli Lilly Now Selling Zepbound Vials at 50% Discount

(27)

Why Only 3 Companies Make America's Insulin

(29:42)

Why Work at Eli Lilly and Company?

(1:21)

Inside Lilly's Corporate Center

(3:40)

Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine

(30:33)

Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz

(2:53)

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

(9:25)

David A Ricks, Chair and Chief Executive Officer of Eli Lilly and Company

(45:30)

David Ricks - CEO of Eli Lilly | Podcast | In Good Company | Norges Bank Investment Management

(53:36)

Eli Lilly CEO: We have 11 pipeline projects in obesity

(2:22)

Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars

(1:4)

Pfizer is 'deeply sorry'

(13:46)

Broadcom CEO Hock Tan on CNBC's \

(8:14)

16 Years of Jacknjellify! 🎂 (Music Video)

(2:39)

Lilly's profit forecast brings relief amid Zepbound miss | REUTERS

(1:5)